Hasil Pencarian - Kenneth O’byrne
- Menampilkan 1 - 15 hasil dari 15
-
1
PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance oleh Maddison Rose, Joshua T. Burgess, Kenneth O’Byrne, Kenneth O’Byrne, Derek J. Richard, Emma Bolderson
Diterbitkan 2020-09-01
Artikel -
2
-
3
The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer oleh Joanna Kapeleris, Joanna Kapeleris, Arutha Kulasinghe, Arutha Kulasinghe, Majid E. Warkiani, Majid E. Warkiani, Ian Vela, Ian Vela, Liz Kenny, Kenneth O'Byrne, Kenneth O'Byrne, Kenneth O'Byrne, Chamindie Punyadeera, Chamindie Punyadeera
Diterbitkan 2018-08-01
Artikel -
4
-
5
Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells. oleh Magdalena Circu, James Cardelli, Martin P Barr, Kenneth O'Byrne, Glenn Mills, Hazem El-Osta
Diterbitkan 2017-01-01
Artikel -
6
Correction: Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung ca... oleh Magdalena Circu, James Cardelli, Martin P Barr, Kenneth O'Byrne, Glenn Mills, Hazem El-Osta
Diterbitkan 2018-01-01
Artikel -
7
Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update oleh Joanna Kapeleris, Joanna Kapeleris, Majid Ebrahimi Warkiani, Arutha Kulasinghe, Arutha Kulasinghe, Ian Vela, Ian Vela, Ian Vela, Liz Kenny, Rahul Ladwa, Rahul Ladwa, Kenneth O’Byrne, Kenneth O’Byrne, Chamindie Punyadeera, Chamindie Punyadeera, Chamindie Punyadeera
Diterbitkan 2022-03-01
Artikel -
8
-
9
-
10
Glycan Profiling in Small Extracellular Vesicles with a SERS Microfluidic Biosensor Identifies Early Malignant Development in Lung Cancer oleh Quan Zhou, Xueming Niu, Zhen Zhang, Kenneth O'Byrne, Arutha Kulasinghe, David Fielding, Andreas Möller, Alain Wuethrich, Richard J. Lobb, Matt Trau
Diterbitkan 2024-09-01
Artikel -
11
Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer oleh Joanna Kapeleris, Juliana Müller Bark, Shanon Ranjit, Darryl Irwin, Gunter Hartel, Majid Ebrahimi Warkiani, Paul Leo, Connor O'Leary, Rahul Ladwa, Kenneth O'Byrne, Brett G.M. Hughes, Chamindie Punyadeera
Diterbitkan 2022-07-01
Artikel -
12
Protein Tyrosine Phosphatase Non-Receptor 11 (<i>PTPN11</i>/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC) oleh Cathy E. Richards, Yasir Y. Elamin, Aoife Carr, Kathy Gately, Shereen Rafee, Mattia Cremona, Emer Hanrahan, Robert Smyth, Daniel Ryan, Ross K. Morgan, Susan Kennedy, Lance Hudson, Joanna Fay, Kenneth O’Byrne, Bryan T. Hennessy, Sinead Toomey
Diterbitkan 2023-06-01
Artikel -
13
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE oleh Lavinia Tan, Chris Brown, Antony Mersiades, Chee Khoon Lee, Thomas John, Steven Kao, Genni Newnham, Kenneth O’Byrne, Sagun Parakh, Victoria Bray, Kevin Jasas, Sonia Yip, Stephen Q. Wong, Sarah Ftouni, Jerick Guinto, Sushma Chandrashekar, Stephen Clarke, Nick Pavlakis, Martin R. Stockler, Sarah-Jane Dawson, Benjamin J. Solomon
Diterbitkan 2024-02-01
Artikel -
14
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples oleh Sinead Toomey, Aoife Carr, Mateusz Janusz Mezynski, Yasir Elamin, Shereen Rafee, Mattia Cremona, Clare Morgan, Stephen Madden, Khairun I. Abdul-Jalil, Kathy Gately, Angela Farrelly, Elaine W. Kay, Susan Kennedy, Kenneth O’Byrne, Liam Grogan, Oscar Breathnach, Patrick G. Morris, Alexander J. Eustace, Joanna Fay, Robert Cummins, Anthony O’Grady, Roshni Kalachand, Norma O’Donovan, Fergal Kelleher, Aine O’Reilly, Mark Doherty, John Crown, Bryan T. Hennessy
Diterbitkan 2020-02-01
Artikel -
15
ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance oleh Malinda Itchins, BMedSci, M.B.B.S., FRACP, PhD, Shirley Liang, BSc, Chris Brown, MBiostats, BSc, Tristan Barnes, BSc (Med), M.B.B.S., FRACP, Gavin Marx, BSc, M.B.B.S., FRACP, Venessa Chin, M.B.B.S., FRACP, PhD, Steven Kao, BHB, MBChB, PhD, FRACP, Po Yee Yip, MBChB, FRACP, PhD, Antony J. Mersiades, BMedSc, M.B.B.S., FRACP, MMed (Clin. Epi), Adnan Nagrial, M.B.B.S., FRACP, PhD, Victoria Bray, M.B.B.S., FRACP, PhD, Geoffrey Peters, BPharm, M.B.B.S., FRACP, Sagun Parakh, BSc, MBChB, FRACP, PhD, Kavita Garg, PhD, Bob T. Li, MD, PhD, MPH, Matthew McKay, PhD, Kenneth O'Byrne, M.B.B.S., FRACP, FRCPA, MD, Thomas John, M.B.B.S., FRACP, PhD, Anthony J. Gill, MD, FRCPA, Mark P. Molloy, PhD, Benjamin J. Solomon, M.B.B.S., FRACP, PhD, Nick Pavlakis, BSc, M.B.B.S., MMed (Clin. Epi), PhD, FRACP
Diterbitkan 2024-09-01
Artikel